Delivery Timing in Morbidly Adherent Placentas: a Randomized, Controlled Trial
试验速览
- 阶段
- 不适用
- 状态
- 撤回
- 主要终点
- Composite neonatal morbidity
研究概览
简要总结
This is a randomized controlled trial to investigate the optimal timing of delivery in clinically stable women with a suspected morbidly adherent placenta.
详细描述
This is a randomized controlled trial to investigate the optimal timing of delivery in clinically stable women with a suspected morbidly adherent placenta dispositioned for a scheduled delivery. The primary outcome will be assessed by comparing the composite neonatal morbidity and composite maternal morbidity between the two groups (delivery at 34 versus 36 weeks gestational age).
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Parallel
- 主要目的
- Other
- 盲法
- None
入排标准
- 年龄范围
- 18 Years 至 50 Years（Adult）
- 性别
- Female
- 接受健康志愿者
- 是
入选标准
- •Women with monographically morbidly adherent placenta with or without a placenta previa.
- •Scheduled delivery via cesarean hysterectomy
排除标准
- •Delivery planned prior to 36 weeks (e.g. non-reassuring fetal status, preterm labor, severe preeclampsia, other medical/fetal indication for delivery as determined by the managing physician).
研究组 & 干预措施
Scheduled delivery at 34 weeks
Scheduled delivery at 34 weeks (range 33 weeks 5 days to 34 weeks 3 days)
干预措施: Scheduled timing of delivery (Other)
Scheduled delivery at 36 weeks
Scheduled delivery at 36 weeks (range 35 weeks 5 days to 36 weeks 3 days)
干预措施: Scheduled timing of delivery (Other)
结局指标
主要结局
Composite neonatal morbidity
时间窗: Within 72 hours of newborn discharge
Maternal neonatal morbidity
时间窗: Within 72 hours of patient discharge
次要结局
未报告次要终点